scispace - formally typeset
D

Dipanwita Mitra

Researcher at University of Mississippi Medical Center

Publications -  19
Citations -  546

Dipanwita Mitra is an academic researcher from University of Mississippi Medical Center. The author has contributed to research in topics: Heparan sulfate & Viral entry. The author has an hindex of 7, co-authored 15 publications receiving 205 citations.

Papers
More filters
Journal ArticleDOI

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.

TL;DR: Several sulfated polysaccharides show potent anti-SARS-CoV-2 activity and can be developed for prophylactic as well as therapeutic purposes, according to structure-based differences in antiviral activity and affinity to SGP.
Posted ContentDOI

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

TL;DR: The low serum bioavailability of intranasally administered UFH, along with data suggesting that the nasal epithelium is a portal for initial infection and transmission, suggest that intranASal administration of UFH may be an effective and safe prophylactic treatment.
Journal ArticleDOI

The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles

TL;DR: The reported data show that antibody attached gold nanoparticles bind to SARS-CoV-2 spike protein, thereby inhibiting the virus from binding to cell receptors, which stops virus infection and spread and has the capability to destroy the lipid membrane of the virus.
Journal ArticleDOI

Aptamer Conjugated Gold Nanostar-Based Distance-Dependent Nanoparticle Surface Energy Transfer Spectroscopy for Ultrasensitive Detection and Inactivation of Corona Virus.

TL;DR: In this article, the authors demonstrate that Rhodamine 6G (Rh-6G) dye conjugated DNA aptamer-attached gold nanostar (GNS)-based distance-dependent nanoparticle surface energy transfer (NSET) spectroscopy has the capability of rapid diagnosis of specific SARS-CoV-2 spike recombinant antigen or SARS -CoV -2 spike protein pseudotyped baculovirus within 10 min.